BRPI0516526A - processo e intermediários de preparação de derivados de n-(1benzidril-azetidin-3-il) n-fenil-metilsulfonamida - Google Patents
processo e intermediários de preparação de derivados de n-(1benzidril-azetidin-3-il) n-fenil-metilsulfonamidaInfo
- Publication number
- BRPI0516526A BRPI0516526A BRPI0516526-1A BRPI0516526A BRPI0516526A BR PI0516526 A BRPI0516526 A BR PI0516526A BR PI0516526 A BRPI0516526 A BR PI0516526A BR PI0516526 A BRPI0516526 A BR PI0516526A
- Authority
- BR
- Brazil
- Prior art keywords
- azetidin
- phenylmethylsulfonamide
- benzhydryl
- intermediates
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
PROCESSO E INTERMEDIáRIOS DE PREPARAçãO DE DERIVADOS DE N-(1-BENZIDRIL-AZETIDIN-3-IL)-N-FENIL-METILSUL-FONAMIDA ". A invenção refere-se a um processo de síntese da N-{1-¢bis-(4-clorofenil)metil!azetid in-3-iI}-N-(3,5-difluorfenil)-metilsulfonamida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0410845A FR2876689B1 (fr) | 2004-10-14 | 2004-10-14 | Nouveau procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide |
PCT/FR2005/002489 WO2006040464A1 (fr) | 2004-10-14 | 2005-10-10 | Procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0516526A true BRPI0516526A (pt) | 2008-09-09 |
Family
ID=34953744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0516526-1A BRPI0516526A (pt) | 2004-10-14 | 2005-10-10 | processo e intermediários de preparação de derivados de n-(1benzidril-azetidin-3-il) n-fenil-metilsulfonamida |
Country Status (32)
Country | Link |
---|---|
US (3) | US7429668B2 (pt) |
EP (1) | EP1802571B1 (pt) |
JP (1) | JP4971986B2 (pt) |
KR (1) | KR20070063540A (pt) |
CN (1) | CN101039903A (pt) |
AR (1) | AR051389A1 (pt) |
AT (1) | ATE534624T1 (pt) |
AU (1) | AU2005293453A1 (pt) |
BR (1) | BRPI0516526A (pt) |
CA (1) | CA2581781A1 (pt) |
CR (1) | CR9008A (pt) |
CY (1) | CY1112390T1 (pt) |
DK (1) | DK1802571T3 (pt) |
EA (2) | EA200801990A1 (pt) |
ES (1) | ES2378181T3 (pt) |
FR (1) | FR2876689B1 (pt) |
HR (1) | HRP20120168T1 (pt) |
IL (1) | IL182277A0 (pt) |
MA (1) | MA29005B1 (pt) |
ME (1) | ME01297B (pt) |
MX (1) | MX2007004483A (pt) |
NO (1) | NO20072431L (pt) |
PL (1) | PL1802571T3 (pt) |
PT (1) | PT1802571E (pt) |
RS (1) | RS52132B (pt) |
SG (2) | SG144920A1 (pt) |
SI (1) | SI1802571T1 (pt) |
TN (1) | TNSN07115A1 (pt) |
TW (1) | TW200626542A (pt) |
UY (1) | UY29165A1 (pt) |
WO (1) | WO2006040464A1 (pt) |
ZA (1) | ZA200703011B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2925050B1 (fr) * | 2007-12-14 | 2010-01-08 | Sanofi Aventis | Nouveau procede de preparation de derives d'azetidine |
ES2416071T3 (es) * | 2009-06-29 | 2013-07-30 | Merz Pharma Gmbh & Co. Kgaa | Método para preparar 1-amino-1,3,3,5,5-pentametilciclohexano |
WO2011000538A1 (en) * | 2009-06-29 | 2011-01-06 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing neramexane |
CN107089918B (zh) * | 2017-04-08 | 2020-06-16 | 迪嘉药业集团有限公司 | 一种盐酸二苯甲胺的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9714129D0 (en) * | 1997-07-04 | 1997-09-10 | Pfizer Ltd | Azetidines |
US6566356B2 (en) * | 2000-03-03 | 2003-05-20 | Aventis Pharma S.A. | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
FR2814678B1 (fr) * | 2000-10-04 | 2002-12-20 | Aventis Pharma Sa | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite |
-
2004
- 2004-10-14 FR FR0410845A patent/FR2876689B1/fr not_active Expired - Fee Related
-
2005
- 2005-10-10 WO PCT/FR2005/002489 patent/WO2006040464A1/fr active Application Filing
- 2005-10-10 ZA ZA200703011A patent/ZA200703011B/xx unknown
- 2005-10-10 EA EA200801990A patent/EA200801990A1/ru unknown
- 2005-10-10 PT PT05809316T patent/PT1802571E/pt unknown
- 2005-10-10 SI SI200531476T patent/SI1802571T1/sl unknown
- 2005-10-10 JP JP2007536213A patent/JP4971986B2/ja not_active Expired - Fee Related
- 2005-10-10 ME MEP-2012-19A patent/ME01297B/me unknown
- 2005-10-10 EA EA200700842A patent/EA012523B1/ru not_active IP Right Cessation
- 2005-10-10 KR KR1020077008412A patent/KR20070063540A/ko not_active Application Discontinuation
- 2005-10-10 CA CA002581781A patent/CA2581781A1/fr not_active Abandoned
- 2005-10-10 AU AU2005293453A patent/AU2005293453A1/en not_active Withdrawn
- 2005-10-10 SG SG200805167-4A patent/SG144920A1/en unknown
- 2005-10-10 DK DK05809316.2T patent/DK1802571T3/da active
- 2005-10-10 PL PL05809316T patent/PL1802571T3/pl unknown
- 2005-10-10 EP EP05809316A patent/EP1802571B1/fr active Active
- 2005-10-10 CN CNA2005800350930A patent/CN101039903A/zh active Pending
- 2005-10-10 AT AT05809316T patent/ATE534624T1/de active
- 2005-10-10 RS RS20120060A patent/RS52132B/en unknown
- 2005-10-10 ES ES05809316T patent/ES2378181T3/es active Active
- 2005-10-10 SG SG200805168-2A patent/SG144921A1/en unknown
- 2005-10-10 BR BRPI0516526-1A patent/BRPI0516526A/pt not_active IP Right Cessation
- 2005-10-10 MX MX2007004483A patent/MX2007004483A/es active IP Right Grant
- 2005-10-13 TW TW094135609A patent/TW200626542A/zh unknown
- 2005-10-13 AR ARP050104295A patent/AR051389A1/es unknown
- 2005-10-14 UY UY29165A patent/UY29165A1/es unknown
-
2007
- 2007-03-21 CR CR9008A patent/CR9008A/es not_active Application Discontinuation
- 2007-03-28 TN TNP2007000115A patent/TNSN07115A1/fr unknown
- 2007-03-28 IL IL182277A patent/IL182277A0/en unknown
- 2007-03-28 US US11/692,462 patent/US7429668B2/en active Active
- 2007-05-04 MA MA29868A patent/MA29005B1/fr unknown
- 2007-05-11 NO NO20072431A patent/NO20072431L/no not_active Application Discontinuation
-
2008
- 2008-08-20 US US12/194,644 patent/US7652154B2/en active Active
-
2009
- 2009-12-11 US US12/635,965 patent/US8071788B2/en active Active
-
2012
- 2012-02-20 HR HR20120168T patent/HRP20120168T1/hr unknown
- 2012-02-23 CY CY20121100184T patent/CY1112390T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065178L (no) | Tienopyridinderivater | |
BRPI0519496A2 (pt) | processo para preparar um composto ou uma composiÇço, e, composiÇço | |
BRPI0615705A2 (pt) | processo para preparar um composto, e, composto | |
ITMI20050801A1 (it) | Procedimento per la preparazione di telmisartan | |
TW200745039A (en) | Isotopically substituted pantoprazole | |
BRPI0713314A2 (pt) | Processo para a preparação de 3-(2-hidróxi-5-fenil substituído)-n-alquil-3-fenilpropilaminas | |
MXPA05013751A (es) | Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales. | |
DE50202504D1 (de) | Neue 4-aminofuropyrimidine und ihre verwendung | |
BRPI0606639A2 (pt) | novo processo para a preparação de indóis substituìdos | |
BRPI0516526A (pt) | processo e intermediários de preparação de derivados de n-(1benzidril-azetidin-3-il) n-fenil-metilsulfonamida | |
TW200719889A (en) | Amino acid derivatives | |
MX2009000767A (es) | Sintesis de (2s,5r)-5-etinil-1-{n-(4-metil-1-(4-carboxi-piridin-2- il)piperidin-4-il)glicil}pirrolidina-2-carbonitrilo. | |
NO20062022L (no) | 1-(kinolinamino)- og 1-(isokinolinamino)-substituerte pentan-2-oler, fremgangsmate for fremstilling av disse og anvendelse av den som antiinflammatoriske midler | |
BRPI0607085A2 (pt) | derivados de oximas heterocìclicos, o respectivo processo de preparação e a respectiva utilização como agentes hipoglicemiantes e hipolipemiantes | |
BR0312593A (pt) | Aciluréias substituìdas por uréia e uretano, processo para a sua produção e sua aplicação | |
PL377441A1 (pl) | Sposób wytwarzania stereoizomeru glikopironiowego o konfiguracji R,R (lub S,S) | |
RS52260B (en) | N- (2-hydroxyethyl) -N-methyl-4- (quinoline-8-yl (1- (thiazol-4-ylmethyl) piperidin-4-ylidene) methyl) benzamide, a process for its production as well as its use for treatment PAIN, TENSION AND DEPRESSION | |
DE602006003204D1 (de) | Reinigungsverfahren von Moxonidine | |
ATE441640T1 (de) | Reaktionsprodukt von resorcin und methylethylketon | |
BRPI0408104A (pt) | processo para a produção de tibolona | |
ATE442370T1 (de) | Fungizide 6-phenyl-pyrazolopyrimidin-7-ylamine | |
BRPI0516507A (pt) | produto, processo e intermediários de preparação de derivados de azetidina | |
BR0315348A (pt) | Processo para a preparação de um composto, e composto | |
BR0309872A (pt) | (tioxo) carbonilaminofenil-uracilas substituìdas | |
BR0311761A (pt) | Processo para a preparação de 4,6-dicloro-5-fluorpirimidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |